HuntX Pharma

aliveseed
seed
Stage
2022
Founded
2
Investors

About

HuntX Pharma develops therapies for neurological disorders, particularly those related to axonal transport defects, by creating small molecule drugs aimed at reversing the progression of conditions such as Huntington's disease.

Explore HuntX Pharma's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.